These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8849716)

  • 21. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Basic and clinical study of senile dementia].
    Hirai S
    Seishin Shinkeigaku Zasshi; 1993; 95(9):693-701. PubMed ID: 8265732
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
    Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Golgi apparatus and the pathogenesis of Alzheimer's disease.
    Dal Canto MC
    Am J Pathol; 1996 Feb; 148(2):355-60. PubMed ID: 8579097
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular aspects of Alzheimer neurofibrillary pathology.
    Kosik KS
    Prog Clin Biol Res; 1992; 379():183-93. PubMed ID: 1409744
    [No Abstract]   [Full Text] [Related]  

  • 26. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research towards tau imaging.
    Jensen JR; Cisek K; Funk KE; Naphade S; Schafer KN; Kuret J
    J Alzheimers Dis; 2011; 26 Suppl 3():147-57. PubMed ID: 21971459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 30. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
    Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
    Perry G; Richey PL; Siedlak SL; Smith MA; Mulvihill P; DeWitt DA; Barnett J; Greenberg BD; Kalaria RN
    Am J Pathol; 1993 Dec; 143(6):1586-93. PubMed ID: 7504885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual action of memantine in Alzheimer disease: a hypothesis.
    Wu TY; Chen CP
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):273-7. PubMed ID: 19797019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2010; 22(1):65-72. PubMed ID: 20847423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
    Deters N; Ittner LM; Götz J
    Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
    Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amyloid cascade hypothesis.
    Korczyn AD
    Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.